Abstract

CommentaryReducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapyJ S Tobias, J S Vaidya, M Keshtgar, D P D'Souza and M BaumJ S TobiasMeyerstein Institute of Oncology and Academic Department of Surgery, University College London Hospitals NHS Trust, London, UKSearch for more papers by this author, J S VaidyaMeyerstein Institute of Oncology and Academic Department of Surgery, University College London Hospitals NHS Trust, London, UKSearch for more papers by this author, M KeshtgarMeyerstein Institute of Oncology and Academic Department of Surgery, University College London Hospitals NHS Trust, London, UKSearch for more papers by this author, D P D'SouzaMeyerstein Institute of Oncology and Academic Department of Surgery, University College London Hospitals NHS Trust, London, UKSearch for more papers by this author and M BaumMeyerstein Institute of Oncology and Academic Department of Surgery, University College London Hospitals NHS Trust, London, UKSearch for more papers by this authorPublished Online:5 Mar 2014https://doi.org/10.1259/bjr/17186381SectionsPDF/EPUBFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail About References 1 Gorman C. Rethinking breast cancer. Time Magazine 2002;159:46–54. Google Scholar2 Bartelink H, Horiot J-C, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378–87. Crossref Medline ISI, Google Scholar3 Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trial. Lancet 1998;351:1451–67. Crossref Medline ISI, Google Scholar4 Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for breast cancer: an overview of the randomised trials. Lancet 1998;352:930–42. Crossref Medline ISI, Google Scholar5 Baum M, Buzdar UA, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T. ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359:2131–9. [Erratum. Lancet 2002;360:1520.] Crossref Medline ISI, Google Scholar6 Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women (part I). Lancet 1992;339:1–15. Medline ISI, Google Scholar7 Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on psychological morbidity associate with diagnosis and treatment of breast cancer. Br Med J 1986;293:1331–4. Crossref Medline, Google Scholar8 Tobias JS. Radiotherapy and breast conservation. Br J Radiol 1986;59:653–66. Link ISI, Google Scholar9 Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757–70. Crossref Medline ISI, Google Scholar10 Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 1990;61:866–8. Crossref Medline ISI, Google Scholar11 Lind PA, Gagliardi G, Wennberg B, Fornander T. A descriptive study of pulmonary complications after post-operative radiation therapy in node-positive stage II breast cancer. Acta Oncol 1997;36:509–15. Crossref Medline ISI, Google Scholar12 Royal College of Radiologists. Report of the Independent Review Commissioned by The Royal College to Brachial plexus neuropathy following radiotherapy for breast carcinoma. Independent Review. [eds T Bates and R G B Evans]. London: Royal College of Radiologists, 1995. Google Scholar13 Meinardi MT, van Veldhuisen DJ, Gietema JA, et al. Prospective evaluation of early cardiac damage induced by epirubicin containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol 2001;19:2746–53. Crossref Medline ISI, Google Scholar14 Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment for early breast cancer: a report after ten years of a clinical trial. Br Med J 1972;2:423–9. Crossref Medline, Google Scholar15 Orecchia R, Veronesi U. The Milan Trial. 3rd European Breast Cancer Conference; Barcelona; March 2002. Eur J Cancer 30; Suppl. 3:S90 (abstract 193). Google Scholar16 Veronesi U. Intraoperative radiotherapy: rationale, techniques, results. Proceedings, 3rd European Breast Cancer Conference, Barcelona, March 2002: Eur J Cancer 38; Suppl. 3:S89 (abstract 190). Google Scholar17 Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001;37:2178–83. Crossref Medline ISI, Google Scholar18 Veronesi U, Vicini F, Orecchia R. Highlights of surgery and radiotherapy. The Breast 2002;11:194–5. Crossref ISI, Google Scholar19 Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit). Ann Oncol 2001;12:1–6. Crossref ISI, Google Scholar20 Vaidya JS, Baum M, Tobias JS, et al. The novel technique of delivering targeted intra-operative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 2002;28:447–54. Crossref Medline ISI, Google Scholar21 Vaidya JS, Hall-Craggs M, Baum M, Tobias JS, et al. Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. Lancet Oncol 2002;3:252–3. Crossref Medline ISI, Google Scholar22 Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: whole organ analysis and clinical implications. Br J Cancer 1996;74:820–4. Crossref Medline ISI, Google Scholar23 Vaidya JS, Baum M, Tobias JS, et al. Targeted intraoperative radiotherapy for breast cancer (Targit)—a randomised trial. Breast Cancer Res Treat 2001;69:145. Google Scholar24 Vaidya JS, Baum M. Clinical and biological implications of the Milan breast conservation trials. Eur J Cancer 1998;34:1143–4. Crossref Medline ISI, Google Scholar25 Baum M, Vaidya JS, Mittra I. Multicentricity and recurrence of breast cancer. Lancet 1997;349:208. Crossref Medline ISI, Google Scholar26 Cosgrove GR, Hochberg FH, Pardo FS, et al. Interstitial irradiation of brain tumors using a miniature radiosurgery device: initial experience. Neurosurgery 1997;40:518–25. Medline ISI, Google Scholar27 Douglas RM, Beatty J, Gall K, et al. Dosimetric results from a feasibility study of a novel radiosurgical source for irradiation of intracranial metastases. Int J Radiat Oncol Biol Phys 1996;36:443–50. Crossref Medline ISI, Google Scholar28 Vaidya JS, Tobias JS, Houghton J, Joseph D, Wenz F, Hilaris BS, et al. Intra-operative breast radiation: the targeted intraoperative radiotherapy (Targit) trial. Br Cancer Res Treat 2003;82(Suppl. 1):S2–S3. Google Scholar29 Doleckova M. The problem of the planning of electron boost in breast cancer. Presented at ISRO 2001, Melbourne, Australia. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited byEffect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival9 July 2020 | JAMA Oncology, Vol. 6, No. 7An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial)1 September 2016 | Health Technology Assessment, Vol. 20, No. 73Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to dateG G Hanna and A M Kirby13 April 2015 | The British Journal of Radiology, Vol. 88, No. 1049Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialThe Lancet, Vol. 383, No. 9917Breast brachytherapy devices9 January 2014 | Expert Review of Medical Devices, Vol. 6, No. 3Multicatheter hybrid breast brachytherapy: A potential alternative for patients with inadequate skin distanceBrachytherapy, Vol. 7, No. 4Secondary Angiosarcoma of the Breast: Can Imaging Findings Aid in the Diagnosis?The Breast Journal, Vol. 14, No. 3Functional intercomparison of intraoperative radiotherapy equipment – Photon Radiosurgery System1 December 2007 | Radiation Oncology, Vol. 2, No. 1Three-dimensional quantitative dose reduction analysis in MammoSite balloon by Monte Carlo calculations20 November 2007 | Journal of Applied Clinical Medical Physics, Vol. 8, No. 4Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boostInternational Journal of Radiation Oncology*Biology*Physics, Vol. 66, No. 5Locoregional therapy of breast cancer: maximizing control, minimizing morbidity10 January 2014 | Expert Review of Anticancer Therapy, Vol. 6, No. 9Breast-conserving Surgery with Intra-operative Radiotherapy: The Right Approach for the 21st Century?Clinical Oncology, Vol. 18, No. 3Radiation Therapy for Breast CancerHematology/Oncology Clinics of North America, Vol. 20, No. 2Update on accelerated partial-breast irradiationCurrent Oncology Reports, Vol. 8, No. 1MammoSite ®9 January 2014 | Expert Review of Medical Devices, Vol. 2, No. 4Dose perturbations due to contrast medium and air in MammoSite ® treatment: An experimental and Monte Carlo study20 June 2005 | Medical Physics, Vol. 32, No. 7Part1Accelerated Partial Breast Irradiation As a Part of Breast Conservation TherapyJournal of Clinical Oncology, Vol. 23, No. 8Partial-breast treatment for early breast cancer: emergence of a new paradigmNature Clinical Practice Oncology, Vol. 2, No. 1Applying Innovations in Surgical and Radiation Oncology to Breast Conservation TherapyThe Breast Journal, Vol. 11, No. s1Source location and dose verification for X-ray intra-operative radiotherapy (IORT) Volume 77, Issue 916April 2004Pages: 273-364 © The British Institute of Radiology History ReceivedApril 04,2003AcceptedSeptember 22,2003Published onlineMarch 05,2014 Metrics Download PDF

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call